For investors looking to break into the booming life sciences asset class, location is king – at least for now.
"Investors are focusing on specific markets," writes Real Capital Analytics' Jim Costello in a new post – but he notes that while "location may matter for life sciences assets for now, [it's] not forever."
The top life sciences firms are clustering in markets with major research institutions, with Boston, San Jose, San Francisco, the East Bay region, and Seattle rounding out the top five for the four quarters ending in Q3 2021. San Diego, Philadelphia, Manhattan, Los Angeles, and Orange County follow behind to round out the top 10 US R&D markets.
Continue Reading for Free
Register and gain access to:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
*May exclude premium content
Already have an account?
Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
